Paradise Genomics has currently partnered with leading institutions to acquire highly qualified clinical samples that lead to the discovery of dynamic biomarkers. We welcome new partnerships that can lead to actionable discoveries in any disease.
The Company is open to partner in a number of capacities, and has the ability to: